33 results
8-K
SLRN
Acelyrin Inc
11 Jun 24
Submission of Matters to a Vote of Security Holders
5:05pm
the selection by the Board's Audit Committee of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year
DEF 14A
SLRN
Acelyrin Inc
22 Apr 24
Definitive proxy
4:10pm
directors until the 2027 Annual Meeting of Stockholders;
2.To ratify the Audit Committee of the Company’s Board of Directors’ selection … of the Board of Directors
Information Regarding Committees of the Board of Directors
Report of the Audit Committee of the Board of Directors
Board
10-K
EX-31.1
1va snjety5x4
28 Mar 24
Annual report
4:21pm
10-K
iwidpinr9f
28 Mar 24
Annual report
4:21pm
10-K
EX-31.2
buv70wilbh pkvqct
28 Mar 24
Annual report
4:21pm
8-K
uo8n7u3q 0xf
11 Mar 24
ACELYRIN, INC. Announces Positive Top-line Results from Its Global Phase 2b/3 Clinical Trial of Izokibep in Psoriatic Arthritis
8:05am
8-K
EX-99.1
zqg s2ax4nk
27 Nov 23
ACELYRIN, INC. Provides Update on Izokibep Clinical Development Program
4:31pm
8-K
EX-99.1
j5kwb bqkhrf3tm
15 Jun 23
ACELYRIN, INC. Reports First Quarter 2023 Financial Results and Recent Highlights
4:22pm
10-Q
EX-31.2
gzxn1q3dwr tnv
15 Jun 23
Quarterly report
4:19pm
10-Q
EX-31.1
5c3uz4v6
15 Jun 23
Quarterly report
4:19pm
10-Q
5zg0psn9y67ae k5
15 Jun 23
Quarterly report
4:19pm